IIARD International Institute of Academic Research and Development

INTERNATIONAL JOURNAL OF ECONOMICS AND FINANCIAL MANAGEMENT (IJEFM )

E-ISSN 2545-5966
P-ISSN 2695-1932
VOL. 2 NO. 1 2017

---

Systematic Review on economic and managerial analysis of stroke

Davide Di Palma

---

Abstract

Background. Stroke is the third leading cause of death after acute myocardial infarction and cancer, the leading cause of disability and the second cause of dementia, resulting in considerable social and economic costs. Objective. This review of literature, starting from the awareness of the substantial negative impact of stroke in Italy, both clinically and economically, has the main objective of highlighting the economic assessment of preventive strategies that is the assistance routes provided for patients affected by stroke. Methods. A literature review was conducted using two electronic medical journal databases: Scopus and PubMed. The presentation of the results is in compliance with the PRISMA method. Results. In this review process, following the above detailed selection a total of 15 articles were selected, all meeting the inclusion criteria. Of these, 4 are in Italian and 11 are in English. Twelve articles were published between 2009-2014, two in 2007 and one in 2015. Eleven articles performed cost analyses and economic assessments taking as reference only Italian cases while the other articles considered an Italian context together with that of other Countries. Conclusions. The final result to be achieved is to increase the quality of health care assistance, mainly through interventions aimed at reorganizing the assistance approaches, without excessive additional costs, but rather creating quantifiable savings in terms of reduction in beds needed to assist in case of stroke events and, as a result of minor disability and dependence, in terms of reduction of rehabilitative, assistance and social expenditures in the long term

keywords:

Stroke costs; Economic evaluation; Cost-effectiveness; Management.

---

References:

Amaducci, L., Baldereschi, M., DiCarlo, A., Maggi, S., Scarlato, G., Candelise, L., et al. (1997).
Prevalence of chronic diseases in older Italians: comparing self-reported and clinical
diagnoses. International Journal of Epidemiology, 26(5), 995-1002.

Bottacchi, E., Corso, G., Tosi, P., Morosini, M. V., De Filippis, G., Santoni, L., et al. (2012). The
cost of first-ever stroke in Valle d’Aosta, Italy: linking clinical registries and administrative
data. BMC health services research, 12(1), 372.

Capri, S., Veneziano, M.A. (2013). Valutazione economica Rivaroxaban, in Rivaroxaban per la
prevenzione dell’ictus in pazienti con fibrillazione atriale: risultati di una valutazione di
HTA. Quaderni dell'Italian Journal of Public Health, 2(7), 59-79.

Carinci, F., Roti, L., Francesconi, P., Gini, R., Tediosi, F., Di Iorio, T., et al. (2007). The impact of
different rehabilitation strategies after major events in the elderly: the case of stroke and hip
fracture in the Tuscany region. BMC health services research, 7(1), 95.

Cesaroni, G., Agabiti, N., Forastiere, F., & Perucci, C. A. (2009). Socioeconomic differences in
stroke incidence and prognosis under a universal healthcare system. Stroke, 40(8), 2812
2819.

Di Carlo, A., Baldereschi, M., Gandolfo, C., et al. (2003). for the ILSA Working Group. Stroke in
an elderly population. Incidence and impact on survival and daily function. The Italian
Longitudinal Study on Aging. Cerebrovasc Dis, 16:141-50.

Di Gianfilippo, G., Napoli, D., & Santis, D. (2006). L’ictus in Italia: Risultati a 5 Anni de L’Aquila
Stroke Registry (1994-1998) e confronto con studi comparabili di popolazione nazionali ed
Internazionali per una politica di gestione programmata della patologia. Riv Ital
Neurobiol, 2:109 36.

Evers, S. M., Struijs, J. N., Ament, A. J., van Genugten, M. L., Jager, J. H. C., & van den Bos, G.
A. (2004). International comparison of stroke cost studies. Stroke, 35(5), 1209-1215.

Fattore, G., Torbica, A., Susi, A., Giovanni, A., Benelli, G., Gozzo, M., & Toso, V. (2012). The
social and economic burden of stroke survivors in Italy: a prospective, incidence-based,
multi-centre cost of illness study. BMC neurology, 12(1), 137.

Häkkinen, U., Rosenqvist, G., Iversen, T., Rehnberg, C., & Seppälä, T. T. (2015). Outcome, use of
resources and their relationship in the treatment of AMI, stroke and hip fracture at European
hospitals. Health economics, 24(S2), 116-139.

Hays, A. G., Sacco, R. L., Rundek, T., Sciacca, R. R., Jin, Z., Liu, R., et al. (2006). Left ventricular
systolic dysfunction and the risk of ischemic stroke in a multiethnic
population. Stroke, 37(7), 1715-1719.

Hurst, S. A., Forde, R., Reiter-Theil, S., Slowther, A. M., Perrier, A., Pegoraro, R., & Danis, M.
(2007). Physicians' views on resource availability and equity in four European health care
systems. BMC Health Services Research, 7(1), 137.
ISTAT. (2015). Health for all - Italia. from: www.istat.it/it/archivio/14562/

Lucioni, D. C., Mazzi, S., Micieli, G., Sacchetti, M. L., & Toni, D. (2010). Valutazione economica
del trattamento con alteplase di pazienti con ictus ischemico in fase acuta, con riferimento
all’Italia. PharmacoEconomics Italian Research Articles, 12(2), 91-103.

Mahoney, E. M., Wang, K., Arnold, S. V., Proskorovsky, I., Wiviott, S., Antman, E., et al. (2010).
Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients With Acute Coronary
Syndromes and Planned Percutaneous Coronary Intervention Results From the Trial to
Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With
Prasugrel–Thrombolysis in Myocardial Infarction TRITON-TIMI 38. Circulation, 121(1),
71-79.

Masiero, S., Poli, P., Armani, M., Ferlini, G., Rizzello, R., & Rosati, G. (2014). Robotic Upper
Limb Rehabilitation after Acute Stroke by NeReBot: Evaluation of Treatment
Costs. BioMed research international, 2014.

Mureddu, G. F., Tarantini, L., Agabiti, N., Faggiano, P., Masson, S., Latini, R., et al. (2013).
Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction
and pre?clinical (stage B) heart failure in the elderly. Results from ‘PREDICTOR’, a
population based?study in central Italy. European journal of heart failure, 15(10), 1102
1112.

Nichols, M., Townsend, N., Luengo-Fernandez, R., Leal, J., Gray, A., Scarborough, P., Rayner, M.
(2012). European Cardiovascular Disease Statistics 2012. Brussels: European Heart
Network, European Society of Cardiology, Sophia Antipolis.

Piscitelli, P., Iolascon, G., Argentiero, A., Chitano, G., Neglia, C., Marcucci, G., et al. (2012).
Incidence and costs of hip fractures vs strokes and acute myocardial infarction in Italy:
comparative analysis based on national hospitalization records. Clinical interventions in
aging, 7, 575.

Ravasio, R., Pedone, M. P., & Ratti, M. (2014). Analisi di costo efficacia dei nuovi anticoagulanti
orali nella prevenzione dell’ictus in pazienti con fibrillazione atriale non valvolare in
Italia. PharmacoEconomics Italian Research Articles, 16(2-3), 1-10.

Sarti, C., Rastenyte, D., Cepaitis, Z., Tuomilehto, J. (2000). International trends in mortality from
stroke, 1968 to 1994. Stroke, 31:1588-601.

Scaletti, A., Lauro, E., Belfiore, P., Zamparelli, B., Liguori, G., & SIHHS (2014). Impatto
economico delle Stroke Unit in Campania. Ig. Sanità Pubbl, 70:73 96.

Schuetz, C. A., Alperin, P., Guda, S., van Herick, A., Cariou, B., Eddy, D., et al. (2013). A
standardized vascular disease health check in europe: a cost-effectiveness analysis. PloS
one, 8(7), e66454.

Sudlow, C. L. M., Warlow, C. P., & International Stroke Incidence Collaboration. (1997).
Comparable studies of the incidence of stroke and its pathological types results from an
international collaboration. Stroke, 28(3), 491-499.

DOWNLOAD PDF

---

Back